Nadler Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
1,767
+36
+2% +$36.8K 0.18% 42
2026
Q1
$1.59M Sell
1,731
-676
-28% -$685K 0.15% 47
2025
Q4
$2.59M Sell
2,407
-125
-5% -$120K 0.24% 38
2025
Q3
$1.93M Buy
2,532
+125
+5% +$93K 0.18% 42
2025
Q2
$1.88M Sell
2,407
-105
-4% -$81.6K 0.19% 41
2025
Q1
$2.07M Sell
2,512
-229
-8% -$191K 0.23% 39
2024
Q4
$2.12M Buy
2,741
+210
+8% +$174K 0.22% 38
2024
Q3
$2.24M Buy
2,531
+8
+0.3% +$7.19K 0.25% 38
2024
Q2
$2.28M Buy
2,523
+66
+3% +$52.8K 0.27% 35
2024
Q1
$1.91M Buy
2,457
+30
+1% +$21.4K 0.24% 37
2023
Q4
$1.41M Buy
2,427
+65
+3% +$37.9K 0.19% 40
2023
Q3
$1.27M Buy
2,362
+150
+7% +$77.3K 0.19% 41
2023
Q2
$1.04M Buy
2,212
+197
+10% +$82.6K 0.15% 46
2023
Q1
$692K Buy
2,015
+375
+23% +$126K 0.11% 56
2022
Q4
$600K Buy
1,640
+70
+4% +$24.8K 0.1% 54
2022
Q3
$508K Hold
1,570
0.1% 59
2022
Q2
$509K Sell
1,570
-4
-0.3% -$1.2K 0.09% 62
2022
Q1
$451K Buy
1,574
+4
+0.3% +$1.03K 0.07% 71
2021
Q4
$434K Hold
1,570
0.06% 77
2021
Q3
$363K Hold
1,570
0.06% 78
2021
Q2
$360K Hold
1,570
0.06% 77
2021
Q1
$293K Hold
1,570
0.05% 87
2020
Q4
$265K Buy
1,570
+70
+5% +$10.5K 0.05% 89
2020
Q3
$222K Hold
1,500
0.05% 90
2020
Q2
$246K Hold
1,500
0.06% 81
2020
Q1
$208K Buy
+1,500
New +$206K 0.06% 82
2016
Q4
Sell
-2,650
Closed -$213K 86
2016
Q3
$213K Buy
+2,650
New +$212K 0.08% 75

Other funds holding LLY

Nadler Financial Group's LLY Position: Q2 2026 in Review

Nadler Financial Group increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $36.8K and bringing the position to 1,767 shares worth $2.12M. The position accounts for 0.18% of the portfolio, ranked #42.

Nadler Financial Group first reported a position in LLY in Q3 2016 and has held it in 27 quarters since. The position peaked at $2.59M in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nadler Financial Group held 1,767 shares of Eli Lilly worth $2.12M as of Q2 2026.
  • Nadler Financial Group bought 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.18% of Nadler Financial Group's portfolio in Q2 2026, its #42 holding.
  • Nadler Financial Group first reported a position in Eli Lilly in Q3 2016 and has held it in 27 quarters since.
  • Nadler Financial Group's Eli Lilly position peaked at $2.59M in Q4 2025.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nadler Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.